JP6506966B2 - Drug volatilizer - Google Patents

Description

  The present invention relates to a drug volatilizer.

  Conventionally, various forms of drug volatilizers have been proposed in which a drug such as a fragrance is volatilized. Among them, a drug volatilizer for use in a place where vibration occurs, for example, in a car, has also been proposed, but such a drug volatilizer has a problem that the stored liquid drug is spilled. Therefore, as a drug volatilizer used in a car, a gel type which does not use a liquid drug, and a membrane type which a drug does not easily leak even by vibration are often used. In the membrane type, a gas-permeable membrane is used to release the drug volatilized through the membrane to the outside (for example, Patent Document 1).

JP, 2014-94619, A

  However, in the membrane type, there is a problem that usable drugs are limited. For example, when used in a high temperature environment, only drugs that volatilize in a short time could be used. Then, when using the chemical | medical agent which can be utilized in various environments irrespective of temperature etc., the following chemical vaporizers can be considered. That is, while supporting a medicine container by the support attached to the inside of a car, a medicine volatilizer of the type which sucks up the medicine stored in a medicine container with a liquid absorption core, and discharges the volatilized medicine outside can be considered. However, when this type of drug volatilizer is used at a place where vibration occurs, the support may be inclined in the vehicle which is the mounting object, and the drug may be spilled. The present invention was made to solve this problem, and provides a drug volatilizer that can prevent the drug from spilling even if it is a type of drug volatilizer that sucks up the drug with a liquid absorption core. The purpose is to

  The drug volatilizer according to the present invention has an opening at the top, a drug container containing a liquid drug, a liquid absorbent core inserted into the opening of the drug container, and a support for supporting the drug container. And a fixing portion attached to the support for attaching the support to the mounting object, the fixing portion being connected to the support so as to be rotatable without stopping.

  According to this configuration, when the support receives vibration, the support rotates with respect to the fixing portion. Therefore, for example, even if the mounting object is inclined, the support is rotated so that the center of gravity of the support is positioned vertically below the connecting portion between the support and the fixing portion. Therefore, the medicine container can prevent the medicine from being spilled because the opening is maintained facing upward.

  Note that "without stopping" means that the support is completely stopped due to resistance when the support is rotated relative to the fixed part. Therefore, the center of gravity of the support does not stop completely even if it receives some resistance when the mounting object tilts and the support rotates with respect to the fixed part, and the center of gravity of the support If it moves vertically below the connecting part, it is included in the "without stopping" of the present invention. In addition, "rotation" according to the present invention includes not only rotation of 360 degrees or more, but also rotation at an angle smaller than 360 degrees, such as half rotation.

  In the above-mentioned medicine volatilizer, the above-mentioned support body can be provided with a holding part which holds the medicine container so as to sandwich the medicine container from the radially outer side with respect to the axial direction of the opening.

  According to this configuration, since the drug container for containing the drug is held on the support in a radially outward direction with respect to the axial direction of the opening, vibration of the drug container from the radial direction, that is, from the lateral direction Once received, the drug container can be prevented from being detached from the support. As a result, spillage of the drug from the drug container can be prevented.

  In each of the medicine volatilizers, the support covers a first wall surface covering the medicine container from the side opposite to the side where the holding portion is provided, and a cover covering the opening side into which the liquid absorbent core is inserted. And a second wall, the second wall may be configured to allow gas to pass therethrough.

  With this configuration, the following effects can be obtained. That is, the first wall surface can prevent the medicine container from being separated from the support in the direction away from the holding portion. Further, the second wall can prevent the liquid absorbent core from being detached from the medicine container. However, since the second wall is configured to allow passage of gas, the volatilized drug can be released to the outside. Also, by providing a cover, the medicine container can be concealed, and for example, if the first wall is decorated, the decorativeness of the product can be enhanced.

  In each of the medicine volatilizers, the medicine container includes a neck portion in which the opening is formed, and a main body portion whose outer shape is larger than the neck portion and the neck portion is connected, and the holding portion is the neck portion The support is configured to be held, and the support is connected to a first support that contacts the outer peripheral surface of the main body at a vertical position corresponding to the center of gravity of the medicine container, and the first support. And a second support portion which is disposed below the first support portion with a gap from the main body portion.

  According to this configuration, the entire outer peripheral surface of the main body of the medicine container is not supported by the support, but the medicine container abuts on the first support of the supports and a gap is formed between the medicine and the second support. It is empty. Therefore, even if the medicine container receives vibration, at least a part of the vibration can be absorbed by the gap with the second support portion. As a result, it is possible to prevent the drug container from being damaged by an impact from the support when it receives vibration. In addition, since the first support portion is in contact with the outer peripheral surface of the main body portion of the medicine container at a position in the vertical direction corresponding to the center of gravity of the medicine container, when the vibration is received (especially the medicine remaining in the medicine container Even when the amount is reduced), it is possible to prevent large shaking with respect to the support.

  In each of the medicine volatilizers, the medicine container includes a neck portion in which the opening is formed, and a main body portion whose outer shape is larger than the neck portion and the neck portion is connected, and the holding portion is the neck portion The support is configured to be held, the support extends in the vertical direction, and the support is connected to extend toward the neck, and at least a portion of the support contacts the side surface of the main body. A support portion may be provided, and a bottom support portion connected to the lower end portion of the upper and lower support portions and extending to support the bottom surface of the main body portion in the same direction as the holding portion.

  According to this configuration, the main body portion of the medicine container is supported by the holding portion and the bottom support portion so as to be sandwiched from above and below. Therefore, when the medicine container is attached to the support, if there is positional deviation in the vertical direction, The main body portion can not be attached because it contacts the holding portion or the bottom support portion. Thus, the bottom support acts as a guide for attaching the drug container to the support. Further, since the main body portion is supported by the holding portion and the bottom surface support portion so as to be sandwiched in the vertical direction, it is possible to prevent the main body portion from coming off obliquely upward or obliquely downward.

  In each of the medicine volatilizers, the medicine container includes a bottom surface formed immediately below the opening, and an outer peripheral surface extending upward from the periphery of the bottom surface, and at least a part of the lower end portion of the liquid absorbent core And a bottom surface may be configured to abut on any one of the peripheral edges.

  In such a drug container, the drug flowing along the outer peripheral surface and flowing to the bottom is likely to be stored on the periphery of the bottom due to surface tension, but as described above, at least a part of the lower end of the liquid wick is the bottom If it abuts on any of the peripheral edges, the medicine stored on the peripheral edge of the side can be sucked up reliably. As a result, the drug can be used up to the end.

  In each of the medicine volatilizers, the medicine container includes a bottom surface and an outer peripheral surface extending upward from the periphery of the bottom surface, and the inner wall surface of the medicine container has at least a part of the outer peripheral surface from the bottom surface. At least one ridge or groove extending therethrough may be formed.

  When such a ridge or groove is provided, the drug is likely to flow down to the bottom surface by passing along the ridge or groove. As a result, it becomes easy to suck up the medicine which has flowed down by the liquid absorption core.

  In each of the medicine volatilizers, the medicine container has a bottom surface and an outer peripheral surface extending upward from the periphery of the bottom surface, and at least an inner wall surface of the medicine container extends from the outer peripheral surface toward the opening. One ridge or groove may be formed.

  When such a ridge or groove is provided, for example, when the drug container is turned upside down, the drug travels along the outer peripheral surface to the opening side, but the drug travels along the ridge or groove and reliably enters the opening. Because the fluid flows into the fluid supply core, it can be reliably sucked by the fluid absorption core inserted into the opening.

  According to the drug volatilizer according to the present invention, it is possible to prevent spillage of the drug from the drug container due to vibration.

It is a perspective view of a medicine volatilizer concerning this embodiment. It is a side view of FIG. It is a top view of FIG. It is the perspective view which looked at the drug volatilizer of FIG. 1 from back. It is a front view of the medicine container concerning this embodiment. It is a bottom view of the medicine container of FIG. It is the sectional view on the AA line of FIG. FIG. 10 is a perspective view of the support in a second position; It is a front view of FIG. FIG. 10 is a side view of the support with the drug container mounted in a second position; It is a figure of FIG. It is a rear view of FIG. It is a side view of fixed part. It is a front view which shows the usage method of the chemical volatilizer of FIG. It is a sectional view showing other examples of a medicine container. It is a sectional view showing other examples of a medicine container. It is a bottom view which shows the other example of a medicine container.

  Hereinafter, an embodiment of a drug volatilizer according to the present invention will be described with reference to the drawings. In the following, for convenience of description, the left side of FIG. 2 is referred to as the front side or the front side, and the right side is referred to as the back side or the rear side. Moreover, the up-down direction of FIG. 3 is called the width direction. And, the other drawings will be described in this direction. However, these directions do not limit the present invention.

  1 is a perspective view of a drug volatilizer according to this embodiment, FIG. 2 is a side view of FIG. 1, FIG. 3 is a plan view of FIG. 1, and FIG. 4 is a perspective view of the drug volatilizer as viewed from the rear. As shown in FIGS. 1 to 4, the drug volatilizer according to the present embodiment includes a drug container 1 containing a liquid drug, and a liquid-wicking core 2 inserted into the drug container 1 and impregnated with the drug. It has a support 3 for supporting the medicine container 1 and a fixing portion 4 for attaching the support 3 to an object to be mounted. Hereinafter, each of these members will be described in detail.

<1. Drug container>
5 is a front view of the drug container, FIG. 6 is a bottom view of the drug container, and FIG. 7 is a cross-sectional view taken along the line AA of FIG. As shown in FIGS. 5 to 7, the medicine container 1 according to the present embodiment includes a main body 11 having an inverted triangular shape in a front view, and a neck 12 connected to the upper end of the main body 11. These are integrally formed. The main body portion 11 has an inner space surrounded by the bottom surface 111, the pair of side surfaces 112a and 112b, the front surface 113, the rear surface 114, and the upper surface 115, and the medicine is stored in the inner space. The bottom surface 111 is formed in a rectangular shape in plan view, and the left and right edges (peripheral edges) are curved in a convex shape. Further, the pair of side surfaces 112 extend from the left and right edge portions 1111 of the bottom surface 111 so as to be apart from each other obliquely upward. The front surface 113 and the back surface 114 extend upward from the front and rear edges of the bottom surface 111, respectively. The upper surface 115 is formed in a rectangular shape extending generally horizontally so as to connect upper end edges of the pair of side surfaces 112, the front surface 113, and the rear surface 114. The above-described neck 12 is connected to the center of the upper surface 115.

  The neck portion 12 is formed in a cylindrical shape having an opening 121 at the upper end, and is disposed immediately above the bottom surface 111. An annular protrusion 13 is formed on the outer peripheral surface of the neck 12 at a position close to the upper surface 115, and a holding portion described later is disposed in a gap between the protrusion 13 and the upper surface 115. In addition, on the outer peripheral surface of the neck portion 12, a spiral male screw 14 is formed above the protrusion 13. The male screw 14 is adapted to be screwed with a female screw of a cap (not shown). That is, a cap is attached to the neck 12 and is removed at the time of use.

  The inner wall surface of the main body 11 is configured as follows. First, protrusions 16 extending in the left-right direction are formed on the bottom surface 111 and the pair of side surfaces 112. The protrusion 16 extends from near the center in the front-to-rear direction of the bottom surface 111 and the side surface 112 from near the center in the vertical direction of one side surface 112a to near the center in the vertical direction of the other side surface 112b. . Further, a groove is formed in the ridge 16 and extends along the ridge 16.

  In addition, a pair of protrusions 17 a and 17 b are formed on the inner wall surface of the upper surface 115. The ridges 17a and 17b pass near the center of the top surface 115 in the front-rear direction, extend from near the left and right ends of the top surface 115 toward the neck 12, and extend the inner wall surface of the neck 12 to the edge of the opening 121 It extends upward. Grooves are also formed in the ridges 17a and 17b and extend along the ridges 17a and 17b.

  Although the drug container 1 as described above can be formed of various materials, it can be formed of a resin material. In this case, for example, those formed in a divided state near the center in the front-rear direction (the formed ridges 16, 17a, 17b are also divided near the center in the front-rear direction) are bonded or a blow method ( For example, after molding by the injection blow method or direct blow method, the drug container 1 can be formed by scraping the inner wall surfaces of the bottom surface 111 and the side surface 112 or sticking a protrusion. Among the blow methods, when forming the drug container 1 by the direct blow method in particular, a tubular parison is used, and the upper part of the parison is drawn with two molds, and the neck portion on which the male screw 14 and the projection 13 are formed. Only the first part 12 is molded first, and then the lower part of the molded neck 12 is drawn with two molds to form the main body 11 while injecting air into the parison. When the portion lower than the neck portion 12 is sandwiched between the two molds, the ridges 16, 17a and 17b can be molded by causing the resin material in a portion where the molds contact each other to swell.

  Further, the drug container 1 is preferably formed of a transparent or translucent material so that the drug in the inside can be viewed. As a liquid medicine stored in medicine container 1, various things, such as a well-known aroma liquid, a deodorizing liquid, an aroma oil, can be used according to a use.

<2. Absorbent core and mounting structure to drug container>
Next, the attachment structure to the liquid absorbent core 2 and the medicine container 1 will be described. First, as shown in FIG. 7, the mounting member 5 of the liquid absorption core 2 is attached to the medicine container 1, and the liquid absorption core 2 is attached to the medicine container 1 via the mounting member 5. . The mounting member 5 includes a cylindrical mounting body 51 press-fitted to the inner wall surface of the neck portion 12 of the medicine container 1, and a flange portion 52 extending radially outward from the upper edge of the mounting body 51. Then, the liquid absorbent core 2 is inserted into the mounting body 51. Moreover, the flange part 52 is arrange | positioned so that the opening periphery of the neck part 12 may be covered from upper direction.

  Further, a groove (not shown) extending along the vertical direction is formed on the inner wall surface of the mounting body 51, and when the liquid absorbent core 2 is inserted, the liquid absorbent core 2 and the mounting body 51 are formed by this groove. A gap is formed between the The gap communicates the internal space of the medicine container 1 with the outside. Thus, for example, when the internal pressure of the medicine container 1 is increased using the medicine container 1 in a high temperature environment, the air in the medicine container 1 is discharged to the outside through the gap. On the other hand, if such a gap is not provided, when the internal pressure rises, there is a possibility that the medicine may be pushed out excessively through the liquid absorbent core 2.

  Subsequently, the liquid absorbent core 2 will be described. The absorbent core 2 is formed in a cylindrical shape, and is inserted into the mounting body 51 in a state of being in close contact with the inner wall surface of the mounting body 51 as described above. And the length of the liquid absorption core 2 is set as follows. That is, when the lower end of the liquid absorbent wick 2 abuts on the bottom surface 111 of the medicine container 1, the upper end of the liquid absorbent wick 2 is set to be in a state of protruding from the neck 12. At this time, the lower surface of the lower end portion 21 of the liquid absorbent wick 2 is in contact with the bottom surface, and the peripheral edge of the lower end portion 21 is also in contact with the left and right edge portions 1111 of the bottom surface.

  The material which comprises the liquid absorption core 2 will not be specifically limited if it is a material which can suck up a chemical | medical agent and volatilize a chemical | medical agent outside from the part which protrudes from the neck part 12. As shown in FIG. For example, various materials such as paper and cloth can be used.

<3. Support>
Subsequently, the support 3 will be described with reference to FIGS. 8 to 12. 8 is a perspective view of the support in the second position, FIG. 9 is a front view of FIG. 8, FIG. 10 is a side view of the support on which the drug container is mounted in the second position, and FIG. FIG. 12 is a rear view of FIG. 10; However, for convenience of explanation, FIG. 12 shows a state in which the fixing portion is removed.

  As shown in FIGS. 8 to 12, the support 3 includes a support body (upper and lower support portions) 31 for holding the drug container 1 and a cover 32 attached to the support body 31 and covering the drug container 1. The cover 32 can assume a first position covering the medicine container 1 (FIGS. 1 to 4) and a second position (FIGS. 8 to 12) from which the medicine container 1 can be removed. Hereinafter, for convenience of description, the support 3 will be described with reference to both the case where the support 3 can take the first position and the case where the second position can take the position. First, the support body 31 will be described.

  The support main body 31 is a plate-like member in which an upper end portion 311, a middle portion (first support portion) 312, and a lower end portion (second support portion) 313 arranged downward from above are integrally formed. A plate-like holding portion 314 is connected between the upper end portion 311 and the middle portion 312. The upper end portion 311 is formed in a plate shape having a trapezoidal shape in a front view, and an annular attachment portion 315 which protrudes to the back side is formed at the center thereof. As shown in FIG. 10, a notch 3151 is formed on the lower side of the attachment portion 315, and the shaft portion of the fixing portion 4 described later is attached to the hole of the attachment portion 315 from the notch 3151. Further, on the left and right sides of the upper end portion 311, a first locking portion 3111 is formed on the front side, and a second locking portion 3112 is formed on the back side. Further, the first locking portion 3111 is disposed on the intermediate portion 312 side, and the second locking portion 3112 is disposed above the first locking portion 3111. Then, a part of a cover 32 described later is pinched by the first locking portion 3111 and the second locking portion 3112. Further, a hinge 316 is formed on the upper side of the upper end portion 311, and the cover 32 is attached pivotably via the hinge 316.

  The middle portion 312 is formed in a plate shape having a rectangular shape in a front view, and is connected to the lower end of the upper end portion 311. And between the upper end part 311 and the middle part 312, as mentioned above, the holding part 314 holding the neck part 12 of the medicine container 1 is connected. The holding portion 314 includes a pair of holding pieces 3141 a and 3141 b formed in a plate shape, and the holding pieces 3141 extend forward. And these holding pieces 3141 are arrange | positioned with a clearance gap in the center of the left-right direction, and the neck part 12 of the medicine container 1 is hold | maintained in this clearance gap. More specifically, the gap between the two holding pieces 3141a and 3141b is formed in a circular shape in plan view along the outer peripheral surface of the neck 12. However, the gap between the front ends of the two holding pieces 3141a and 3141b is It is narrower than the diameter of the neck 12. Thereby, the securing of the neck 12 is formed. The length of the holding portion 314 in the front-rear direction is preferably longer than half the width of the medicine container 1 in the front-rear direction.

  The intermediate portion 312 is configured to abut on the back surface 114 of the medicine container 1 and extends from the upper end of the main body portion 11 of the medicine container 1 to near the middle portion in the vertical direction of the main body portion 11. More specifically, as shown in FIG. 10, the middle portion 312 extends downward beyond the position in the vertical direction corresponding to the center of gravity G of the medicine container 1.

  The lower end portion 313 is formed in a rectangular plate shape in a front view that extends downward from the lower end of the back surface of the middle portion 312. Thus, the lower end portion 313 is disposed rearward of the middle portion 312, and a gap is formed between the lower end portion 313 and the back surface 114 of the medicine container 1 in contact with the middle portion 312. Further, the width in the left-right direction of the lower end portion 313 is narrower than that of the middle portion 312, and when the medicine container 1 is held by the holding portion 314, the medicine container 1 is interrupted and the lower end 313 is visible from the front It is not supposed to. A bar-shaped projection 317 extending in the vertical direction is formed at the center of the front surface of the lower end portion 313, and the front surface of the projection 317 is on the rear side of the front surface of the middle portion 312. Further, a plate-like bottom support portion 318 having a rectangular shape in plan view is connected to the lower end edge of the lower end portion 313. The bottom support portion 318 protrudes forward with substantially the same length as the holding portion 314, and is configured to abut on the bottom surface 111 of the medicine container 1.

  Subsequently, the cover 32 will be described. The cover 32 is connected to the support main body 31 via the hinge 316, whereby the first position in use covering the medicine container 1 as described above and the second position when the medicine container 1 is attached or detached Can take

  The cover 32 is a front wall (first wall) 321 disposed on the front side of the support main body 31, and an upper wall 322 (second wall) connected to the upper end edge of the front wall 321 and extending in the front-rear direction; And a back wall portion 323 extending vertically from the rear end edge of the upper wall portion 322 and surrounding the periphery of the upper end portion 311 of the support body 31.

  The front wall portion 321 is formed in a rhombic shape in a front view, and the front surface is decorated. The front wall portion 321 is formed in a size such that the medicine container 1 held by the support body 31 is substantially concealed. The upper wall portion 322 is formed in a front view so as to extend along the upper end portion of the front wall portion 321, and is disposed so as to cover the absorbent core 2 inserted into the medicine container 1 from above. An opening is formed in the vicinity of the upper end of the upper wall portion 322, and a plurality of rod-like members 3221 extending in the front-rear direction so as to close a part of the opening are arranged in parallel. The interval at which the rod-like members 3221 are disposed is smaller than the diameter of the liquid absorbent core 2. Thereby, although the chemical | medical agent volatilized from the liquid absorption wick 2 passes through the upper wall part 322, the liquid absorption wick 2 does not come out.

  The back wall portion 323 is formed in a front view to be formed along the rear end edge of the upper wall portion 322, and has a plate shape surrounding the upper end portion 311 of the support main body 31 as described above. It is formed. First, the upper side of the upper end portion 311 of the support main body 31 is connected to the back wall portion 323 via the hinge 316. Further, the inner peripheral edges on both sides of the back wall portion 323 are sandwiched by the first locking portion 3111 and the second locking portion 3112 formed on the upper end portion 311 of the support main body 31. Thereby, the back wall part 323 is fixed to the support main body 31, and the cover 32 is hold | maintained in a 1st position.

  Subsequently, the case where the cover 32 is in the second position will be described. In the first position, as shown in FIGS. 1 to 4, the front wall portion 321 is arranged to extend in the vertical direction so as to be substantially parallel to the support main body 31 because the cover 32 covers the medicine container 1. From this state, when the front wall portion 321 is inclined toward information, the locked state between the first locking portion 3111 and the second locking portion 3112 and the back wall portion 323 is released, and the cover 32 is released from the hinge 316 It can swing around the center. Then, for example, as shown in FIG. 10, the cover 32 swings to a state in which the front wall portion 321 extends horizontally above the support main body 31, and becomes the second position. In this state, the medicine container 1 is removable because it is exposed to the outside.

<4. Fixed part>
Next, the fixing unit 4 will be described with reference to FIG. FIG. 13 is a side view of the fixing portion. The fixing portion 4 is formed to extend from the mounting portion 315 of the upper end portion 311 of the support main body 31 to the back side. More specifically, the connecting portion 43 rotatably connected to the mounting portion 315, the plate-shaped first fixing piece 41 extending rearward from the connecting portion 43, and the lower side of the first fixing piece 41 are parallel to each other. And an extending plate-like second fixing piece 42, which are integrally formed. The connecting portion 43 includes a small diameter shaft portion 431 and a circular retaining portion 432 attached to the front side thereof and having a larger diameter than the shaft portion 431. The shaft portion 431 is cut in the hole of the mounting portion 315 It is attached through the notch 3151. The inner diameter of the mounting portion 315 is substantially the same as that of the shaft portion 431, but smaller than the retaining portion 432, the connecting portion 43 is rotatably mounted at the mounting portion 315 around an axis extending in the front-rear direction. In addition, since the width of the notch 3151 is smaller than the diameter of the shaft portion 431, the notch 3151 serves to prevent the shaft portion 431 from coming off. At this time, the connecting portion 43 rotates with respect to the mounting portion 315 substantially without resistance, whereby, for example, when the supporting body 3 receives a vibration, the supporting body 3 with respect to the fixing portion 4 It is supposed to rotate.

  The first fixing piece 41 and the second fixing piece 42 can be elastically deformed with respect to the connecting portion 43, and thereby, both the fixing pieces 41 and 42 can be deformed so as to be close to and separated from each other. In the initial state, the rear end portions of the two fixing pieces 41 and 42 are in contact with each other, and by pushing and spreading this against the elastic force, the mounting object is elastically made between the two fixing pieces 41 and 42. It can be pinched.

<5. Method of using drug volatilizer>
Next, how to use the drug volatilizer configured as described above will be described. First, the cap of the medicine container 1 is removed to expose the absorbent core 2. Subsequently, the cover 32 of the support 3 is opened to a second position, and the holding portion 314 is exposed. Subsequently, the neck portion 12 of the medicine container 1 is inserted between the holding pieces 3141 a and 3141 b of the holding portion 314. Specifically, the inner edges of both the holding pieces 3141 a and 3141 b are engaged with the gap between the protrusion 13 of the neck 12 and the upper surface 115 of the main body 11. In this state, since the gap on the front end side of both the holding pieces 3141a and 3141b is narrower than the diameter of the neck portion 12, this becomes a retention stop and the neck portion 12 is prevented from being detached from the holding portion 314. Thus, when the neck portion 12 is attached to the holding portion 314, the back surface 114 of the main body portion 11 of the medicine container 1 abuts against the middle portion 312 of the support main body 31, and the bottom surface 111 of the main portion 11 Abut.

  Thus, the holding portion 314 engages with the gap between the protrusion 13 of the neck portion 12 and the upper surface 115 of the main body portion 11. However, when the holding portion 314 is displaced in any of the vertical directions, the bottom surface 111 of the main portion 11 is the bottom support portion. The medicine container 1 can not be attached to the support 3 without contacting the body 318, for example, the main body 11 hits the bottom surface support 318. Therefore, the bottom support 318 also functions as a guide for mounting the medicine container 1 in the correct position.

  Thus, when the medicine container 1 is mounted, the cover 32 is returned to the first position. As a result, the forward movement of the medicine container is restricted by the front wall portion 321 of the cover 32, and the medicine container is prevented from being separated from the support main body 31. Further, since the upper wall portion 322 of the cover 32 covers the absorbent core 2 from the upper side, it is possible to prevent the absorbent core 2 from being separated from the medicine container 1.

  Subsequently, the fixing portion 4 is attached to the mounting target portion. That is, the object to be attached is held between the two fixing pieces 41 and 42 of the fixing portion 4. Thus, the attachment of the drug volatilizer is completed. Although the mounting object is not particularly limited, for example, it can be accompanied by vibration such as an air conditioner of a car or an exhaust port of a defroster. However, the mounting object that causes vibration may be other than the exhaust port as described above, and is not particularly limited.

  Thereafter, the drug in the drug container 1 is sucked up by the liquid absorbent wick 2, passes along the liquid absorbent wick 2, and is volatilized to the outside of the drug container 1. Thereby, an aroma effect etc. can be obtained. And in the medicine volatilizer concerning this embodiment, even if quantity of medicine in medicine container 1 decreases from the following reasons, medicine can be used to the last. First, the lower end 21 of the liquid absorbent wick 2 is in contact with the bottom surface 111 of the medicine container 1, and at least a part of the lower end 21 of the liquid absorbent wick 2 is in contact with the edge 1111 of the bottom 111. Therefore, it is possible to aspirate, among the agents that flowed down from the side surface 112 and reached the bottom surface 111, the agents remaining near the edge of the bottom surface 111 due to surface tension. Further, since the ridge 16 having a groove is formed from the side surface 112 to the bottom surface 111 of the main body portion 11, the medicine can easily flow down to the bottom surface 111 by passing along the ridge 16. As a result, it becomes easy to suck up the medicine which has flowed down by the liquid absorbent core 2. Furthermore, for example, when the medicine container 1 is turned upside down, the medicine accumulates on the upper surface 115 of the main body 11, but the medicine flows along the ridges 17a and 17b of the upper surface 115 to the neck 12, and the liquid absorption core It is sucked into two.

  As described above, since the liquid absorbent core 2 is in contact with the edge of the bottom surface 111 and the protrusions 16 and 17 are formed, the medicine remains in the medicine container 1 of the present embodiment. It is possible to prevent the drug from being used up to the end.

<6. Feature>
As described above, according to the present embodiment, the following features are provided.

<6-1>
Since the fixed portion 4 is rotatably attached to the support 3, the following effects can be obtained. That is, when the support 3 receives vibration, the support 3 rotates with respect to the fixed portion 4. Therefore, for example, even if the attachment object 7 is inclined from the horizontal state shown in FIG. 14A to the inclined state shown in FIG. 14B, the center of gravity of the support 3 is the support 3 and the fixing portion The support 3 is rotated so as to be located vertically below the connecting portion with 4. Therefore, since the medicine container 1 is maintained in the state where the opening 121 is directed upward, the medicine can be prevented from spilling.

<6-2>
Since the neck portion 12 of the drug container 1 containing the drug is held by the holding portion 314 of the support 3 so as to be sandwiched from the left and right, even if the drug container 1 receives vibration from the lateral direction, the drug container 1 Detachment from the support can be prevented. As a result, spillage of the drug from the drug container 1 can be prevented.

<6-3>
The protrusion 13 is formed on the outer peripheral surface of the neck 12, and the 314 holding portion engages with the gap between the protrusion 13 and the upper surface 115 of the main body 11, so that the movement of the medicine container 1 in the vertical direction is restrained. Be done. Therefore, even if the medicine container 1 receives vibration in the vertical direction, it can be prevented from being detached from the support 3.

<6-4>
Since the main body 11 of the medicine container 1 is sandwiched between the holding part 314 and the bottom support 318 in the vertical direction, once the medicine container 1 is mounted on the support 3, It can not be moved obliquely upward or obliquely downward, and the detachment of the medicine container 1 can be prevented.

<6-5>
The entire outer peripheral surface of the main body portion 11 of the medicine container 1 is not supported by the support body 31, but the medicine container 1 is in contact with the middle portion 312 of the support body 31 and a gap is formed with the lower end 313. There is. Therefore, even if the medicine container 1 receives vibration, at least a part of the vibration can be absorbed by the gap with the lower end portion 313. As a result, it is possible to prevent the medicine container 1 from being damaged by an impact from the support body 31 when it receives vibration. Moreover, since the rod-shaped protrusion 317 is formed in the lower end part 313, when the medicine container 1 moves to the clearance side, this protrusion 317 becomes a cushion and contacts.

  Furthermore, when the intermediate portion 312 is in contact with the outer peripheral surface of the main body portion 11 of the drug container 1 at a position in the vertical direction corresponding to the center of gravity G of the drug container 1, vibration (especially in the drug container Even when the remaining amount of the medicine decreases, it is possible to prevent the medicine container 1 from largely shaking relative to the support main body 31.

<7. Modified example>
As mentioned above, although one Embodiment of this invention was described, this invention is not limited to this, A various change is possible unless it deviates from the meaning. The following modifications can be combined as appropriate.

<7-1>
The form of the fixing portion 4 is not particularly limited, as long as it can be fixed to the mounting object. Also, the method of connecting the support portion and the fixing portion is not particularly limited as long as the support portion can be rotated without stopping.
<7-2>
In the above embodiment, the holding portion 314 is engaged between the protrusion 13 of the neck portion 12 and the upper surface 115 of the main body portion 11, but the present invention is not limited to this. That is, the holding portion 314 can also be engaged using the male screw 14 provided on the neck portion 12. Further, the protrusion 13 of the neck 12 does not have to be provided over the entire circumference of the neck 12 and may be a part. Furthermore, a plurality of protrusions 13 may be provided in the axial direction of the neck portion 12, and the holding portion 314 may be engaged between the adjacent protrusions 13.

  The form of the holding portion 314 is not particularly limited, and is not particularly limited as long as the neck portion is held so as to sandwich the neck portion from the radially outer side of the neck portion. Moreover, it is not restricted to a neck part, It can also hold | maintain so that a main-body part may be pinched from radial direction outward.

<7-3>
The form of the support 3 is not particularly limited as long as at least the holding portion 314 is provided. Therefore, the cover 32 may be provided as needed.

<7-4>
The form of the drug container 1 is also not particularly limited, and it is sufficient that the drug wick 2 can be inserted so as to be impregnated with the drug from the opening 121 at least at the top. Therefore, the shape, material, etc. are not particularly limited.

<7-5>
The ridges 16, 17a, 17b formed on the medicine container 1 are formed to transmit the medicine, but are not limited thereto. For example, although the grooves are formed in each of the ridges 16, 17a and 17b, the grooves may not necessarily be provided, and only the ridges 17 may be formed as shown in FIG. In the above embodiment, the ridges are formed (17) from the bottom surface 111 to the side surface 112 of the medicine container 1 (16) and from the top surface 115 to the neck 12 (17a, 17b). Just do it. Also, a plurality of ridges can be provided. Furthermore, instead of the ridges, as shown in FIG. 16, grooves 18 can be formed on the inner wall surface of the medicine container 1.

<7-6>
In the said embodiment, as shown in FIG. 6, although the lower end part 21 of the liquid absorption wick 2 is in contact with the edge 1111 on either side of the bottom face 111 of a medicine container, at least one part should just be in contact. For example, as shown in FIG. 17 (a), the diameter of the lower end 21 of the liquid absorbent wick 2 may be small, and only one edge 1111 may be in contact, and as shown in FIG. 17 (b), the bottom It may be in contact with any edge of 111 (in this example, the back side). Further, the shape of the bottom surface 111 is also not particularly limited, as long as a portion of the lower end portion 21 of the liquid absorbent wick 2 is in contact with any of the edge portions. However, such a configuration is not necessarily required, but is preferably provided.

1: Drug container 11: Body portion 111: Bottom surface 112: Side surface (peripheral surface)
113: Front surface (peripheral surface)
114: back surface (peripheral surface)
115: Top surface (peripheral surface)
12: Neck 121: Opening 13: Projection 2: Liquid absorption core 21: Lower end portion 3: Support body 31: Support body (upper and lower support portions)
312: middle part (first support part)
313: lower end (second support)
314: Holding portion 318: Bottom support portion 32: Cover 4: Fixing portion G: Center of gravity

Claims (5)

A drug container having an opening at the top and containing a liquid drug;
An absorbent core inserted into the opening of the medicine container;
A support for supporting the drug container;
A fixing part attached to the support for attaching the support to an object to be attached;
Equipped with
The fixing portion is connected to the support so as to be rotatable without stopping .
The drug container includes a neck portion in which the opening is formed, and a main body portion having a larger outer shape than the neck portion and to which the neck portion is connected.
The holder is configured to hold the neck,
The support is
A first support that contacts the outer peripheral surface of the main body at a position in the vertical direction corresponding to the center of gravity of the medicine container;
A drug volatilizer comprising: a second support portion connected to the first support portion and disposed below the first support portion with a gap from the main body portion .   The medicine volatilizer according to claim 1, wherein the support includes a holding portion which holds the medicine container so as to sandwich the medicine container from the radially outer side with respect to the axial direction of the opening. The support is
A first wall surface covering the medicine container from the side opposite to the side where the holding portion is provided;
And a second wall surface covering the opening side into which the liquid absorbent core is inserted.
The drug volatilizer according to claim 1, wherein the second wall is configured to allow gas to pass therethrough. Before Symbol support,
An upper and lower support portion extending vertically and being connected so as to extend the holding portion toward the neck portion, and at least a part of which is in contact with an outer peripheral surface of the main body portion;
The bottom support part connected with the lower end part of the said up-and-down support part, and extended so that the bottom face of the said main-body part may be supported in the same direction as the said holding | maintenance part Drug volatilizer. The drug container has a bottom surface formed immediately below the opening, and an outer peripheral surface extending upward from the periphery of the bottom surface,
The chemical volatilizer according to any one of claims 1 to 4 , wherein at least a part of the lower end portion of the liquid absorbent core is configured to abut on any one of the peripheral edges of the bottom surface.

Images